You are here


Momentive Technologies and Stevanato Group Collaborate to Offer Pur Q® Fused Quartz Vials in EZ-fill® Configuration

Agreement delivers ultra-high-purity quartz vials in efficient secondary packaging format to streamline fill-finish operations for early phase drug development
 

Willoughby, Ohio, USA, and Piombino Dese (PD), Italy – October 13, 2020 – Momentive Technologies and Stevanato Group announced today a collaboration agreement to supply Momentive Technologies’ Pur Q® fused quartz vials in the Stevanato Group’s EZ-fill® packaging format. Momentive Technologies’ Pur Q vials are the first ultra-high-purity fused quartz vials available for pharmaceutical packaging. Stevanato Group’s EZ-fill® secondary packaging solution provides a fully integrated, ready-to-use solution for aseptic fill-finish operations. Combined, the offerings will help biopharmaceutical companies improve the reliability and speed of drug development and production of lifesaving medications via highly stable primary packaging and an efficient secondary packaging method.

Momentive Technologies, the largest fused quartz and ceramic solutions provider in the world, designed the revolutionary Pur Q vial as an ultra-high-purity solution for drug storage and delivery. Made from 99.995% pure silicon dioxide (SiO2), the fused quartz vials have an exceptionally inert, nonreactive surface that virtually eliminates any risk of interaction with packaged drug formulations. The innovative vials leverage Momentive Technologies’ nearly 75 years of experience in quartz technologies, including demanding semiconductor and fiber optic applications.

“Momentive Technologies is excited to feature its Pur Q fused quartz vials in the SG EZ-fill®packaging platform. Providing our ultra-high-purity vials to the market in this ready-to-use format allows the industry to screen early stage drug formulations and simply scale up to full production, without changing the container or filling process. Due to the vials’ highly inert properties, biopharmaceutical companies will be able to confidently take the container out of the equation when assessing the viability of formulations, helping to accelerate the development of increasingly complex and sensitive biologic drug formulations,” said Robert Koch, Global Commercial Director at Momentive Technologies.

Stevanato Group, a leading producer of glass primary packaging and provider of integrated capabilities for drug delivery systems, designed its EZ-fill® secondary packaging to mitigate the risk of breakages, cosmetic issues and particulate generation during fill-finish operations. The packaging stores vials safely in a tray, or nest and tub configuration for efficient filling, while minimizing glass-to-glass contact. It is the ideal solution from lab-scale manual filling up to the traditional filling process to enable the accelerated development and widespread commercialization of innovative, lifesaving pharmaceutical and biologic treatments faster than ever before.

“It is with great pride that we announce the agreement with Momentive Technologies to package the company’s ultra-high-purity Pur Q quartz vials in our SG EZ-fill® format. Biopharma companies can now count on an additional robust primary packaging option that complements our ready-to-use secondary packaging solution to enable lean manufacturing, production flexibility and ease of use. In choosing our cost-efficient, scalable EZ-fill® platform, Momentive Technologies has endorsed an industry-verified solution that has been proven over more than a decade by over 30 fill-finish machine manufacturers on more than 250 filling lines,” said Fabio Bertacchini, Director of Product Management at Stevanato Group.

 

For more information, please contact:

Robert Koch,

robert.koch@momentive.com

Fabio Bertacchini,

fabio.bertacchini@stevanatogroup.com

 

About Stevanato Group

Established in 1949, Stevanato Group is the world’s largest, privately-owned designer and producer of glass primary packaging for the pharmaceutical industry. From its outset, the Group has developed its own glass converting technology to ensure the highest standards of quality. The Group comprises a wide set of capabilities dedicated to serving the biopharmaceutical and diagnostic industries: from glass containers with its historical brand Ompi, to high-precision plastic diagnostic and medical components, to contract manufacturing for drug delivery devices, to vision inspection systems, assembly, and packaging equipment. The Group also provides analytical and testing services to study container closure integrity and integration into drug delivery devices, streamlining the drug development process. Thanks to its unique approach as a one-stop-shop, Stevanato Group can offer an unprecedented set of solutions to biopharma companies for a faster time to market and a reduced total cost of ownership. For more information, please visit www.stevanatogroup.com.

 

About Momentive Technologies

Momentive Technologies delivers purity that inspires progress. Leveraging a nearly 75-year legacy of innovation, the company’s ultra-high-purity quartz products help enable high-quality processing and production for a wide range of applications in the semiconductor, photovoltaic, lighting, water purification, consumer electronics and telecommunications industries. The company is the world leader in fused quartz and ceramic solutions and has an unrivaled ability to supply custom material solutions at scale to the highest standards of quality. By engineering custom materials with uncommon purity and unwavering precision, Momentive Technologies gives customers the freedom to think big and develop transformative products that benefit mankind on the grandest of scales. Together, Momentive Technologies and its customers are reshaping the world. For more information, please contact us at PurQ@momentive.com.

Contact Person: 
Robert Koch
website: 
https://www.stevanatogroup.com/
Email: 
robert.koch@momentive.com
ADD CONTENT